Assembly Biosciences, Inc. (ASMB)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Assembly Biosciences, Inc. (ASMB) is down 27.8% since the beginning of the year. At $25 per share, ASMB is trading 38.1% below its 52-week high of $40. Investors who bought $1,000 worth of ASMB shares 5 years ago would now be looking at an investment worth $530.

Assembly Biosciences, Inc. (ASMB) has returned -27.76% so far this year and 61.64% over the past 12 months. Over the last ten years, ASMB has returned -9.76% per year, falling short of the S&P 500 Index benchmark, which averaged 13.66% annually.

Based on dividend-adjusted daily data since Dec 17, 2010, ASMB's average daily return is +0.18%, while the average monthly return is +2.77%. At this rate, an investment would double in approximately 2.1 years.

Historically, 43% of months were positive and 57% were negative. The best month was Jul 2014 with a return of +383.2%, while the worst month was Feb 2014 at -67.9%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, ASMB closed higher 47% of trading days. The best single day was Jul 15, 2014 with a return of +527.6%, while the worst single day was Nov 6, 2020 at -69.4%.

Assembly Biosciences, Inc. has an annualized alpha of 36.71%, beta of 0.98, and R2 of 0.01 versus S&P 500 Index. Calculated based on daily prices since December 20, 2010.

• This stock participated in 99.64% of S&P 500 Index downside but only 22.19% of its upside - more exposed to losses than it benefited from rallies.
• R2 of 0.01 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ASMB ranks 70 for risk / return — better than 70% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

The table below present risk-adjusted performance metrics for Assembly Biosciences, Inc. (ASMB) and compare them to S&P 500 Index.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Assembly Biosciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Assembly Biosciences, Inc. was 98.99%, occurring on Nov 22, 2023. The portfolio has not yet recovered.

The current Assembly Biosciences, Inc. drawdown is 96.81%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Assembly Biosciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Assembly Biosciences, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.